Ziprasidone as an adjuvant for clozapine- or olanzapine-associated medical morbidity in chronic schizophrenia

OBJECTIVE: This study sought to examine the effect of ziprasidone on olanzapine or clozapine associated medical morbidity such as insulin resistance, diabetes mellitus and impaired fasting glucose, obesity and hyperlipidemia in patients with schizophrenia or schizoaffective disorder. METHOD: This wa...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Hum Psychopharmacol
Главные авторы: Henderson, David C., Fan, Xiaoduo, Copeland, Paul M., Sharma, Bikash, Borba, Christina P., Forstbauer, Sharon I., Miley, Kate, Boxill, Ryan, Freudenreich, Oliver, Cather, Corey, Evins, A. Eden, Goff, Donald C.
Формат: Artigo
Язык:Inglês
Опубликовано: 2009
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4327763/
https://ncbi.nlm.nih.gov/pubmed/19283774
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hup.1012
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы